Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell Lymphoma
Clinical trial NCT05504603 · UNKNOWN
Trial details
- NCT number
- NCT05504603
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2023-07-26
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.